NCT06274957Completed
The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation
The Effect of Airway Oscillation and Chest Wall Oscillation on Respiratory Functions and Sleep Quality in COPD Patients in Acute Exacerbation Period and Technical Inspection of Devices
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work .
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 2 Feb 2024
- Start date
- 1 May 2024
- Primary completion date
- 10 Jun 2024
- Lead sponsor
- Saglik Bilimleri Universitesi
- Diseases
- COPD
- NCT number
- NCT06274957
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 1 May 2024 to the primary completion date, 10 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having undergone surgery on the upper extremities, lower extremities, neck, and back.
Other illness
- Systemic fungal infections.
- Having cognitive impairment affecting the decision to participate in the study, such as confusion, orientation disorder, or dementia.
- Patients with lung cancer or metastasis in the lungs.
- Diagnosis of conditions provoking shortness of breath other than COPD exacerbation, such as pneumonia, pneumothorax, heart failure, and pulmonary embolism.
- Presence of a new-onset rhythm disorder or ischemic changes requiring intervention on the EKG, excluding sinus tachycardia and multifocal atrial tachycardia.
- Chronic kidney failure requiring hemodialysis.
- Patients with conditions causing weakness in the lower extremities, such as arthritis, neurological disease, deep vein thrombosis, peripheral artery disease, muscle weakness, fractures, osteoarthritis, etc.
Other
- Having a hospital admission with a diagnosis of asthma attack in the last 5 years.
- Monitoring suspicious focal points for pneumonia on lung radiology.
- Hospitalization due to reasons other than exacerbation despite having a diagnosis of COPD.
- Presence of pulmonary fibrosis or suspicious findings of fibrosis on radiology.
- Having ankylosing spondylitis with a Cobb angle of 10 degrees or more in the radiographic evaluation of the vertebral column.
Who the study is looking for
- Being classified as GOLD stage 3 or 4 based on spirometric evaluation in the medical history.
- Having a hospital admission within the specified time frame, evaluated by a pulmonary specialist, and admitted to the pulmonary diseases service with a diagnosis of COPD exacerbation.
- Being 40 years of age or older.
- Voluntarily agreeing to participate in the study.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Health Sciences Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.